13 min

Episode 3: Ongoing Research for New HAE treatments‪.‬ HAE Speaks

    • Sin fines de lucro

Tony Castaldo, CEO of the HAE Association provides an information packed update on the new HAE treatments that are being developed by 9 companies. Tune in to this  podcast for the latest exciting details about this vitally important HAE research.

Here is a list of companies and their websites listed in order as they are discussed in the podcast.

BioCryst: www.biocryst.com

Kalvista: www.kalvista.com

Phavaris: pharvaris.com

Attune Pharmaceuticals: attunepharma.com

CSL Behring: www.cslbehring.com

BioMarin: www.biomarin.com

RegenxBio: www.regenxbio.com

Intellia Therapeutics: www.intelliatx.com

Ionis Pharmaceuticals: www.ionispharma.com

Tony Castaldo, CEO of the HAE Association provides an information packed update on the new HAE treatments that are being developed by 9 companies. Tune in to this  podcast for the latest exciting details about this vitally important HAE research.

Here is a list of companies and their websites listed in order as they are discussed in the podcast.

BioCryst: www.biocryst.com

Kalvista: www.kalvista.com

Phavaris: pharvaris.com

Attune Pharmaceuticals: attunepharma.com

CSL Behring: www.cslbehring.com

BioMarin: www.biomarin.com

RegenxBio: www.regenxbio.com

Intellia Therapeutics: www.intelliatx.com

Ionis Pharmaceuticals: www.ionispharma.com

13 min